Vol. 4, Issue 2, Part A (2022)

Statins are a widely prescribed class of drugs to lower cholesterol. On 28 February 2012, the United States Food and Drug Administration (FDA) issued a new warning for the labelling of statin drugs regarding potential adverse effects on cognition. This article aims analyse to review the effect of statin therapy on cognition level. We performed a systematic, computer-aided search of MEDLINE, EMBASE, and the Cochrane Central Register from January 2008 to October 2021. The age wise cognition impairment and pointed out the age group from 61-70 years showed the highest impairment. whereas long-term data suggest a beneficial role in the prevention of dementia.